Skip to main content
The module will cover the WHO's approach to governing safe and rational access to medicines; international and national regulatory apparatuses; the global drug development and supply chain; and the role of clinical trials in protecting patients before and after drugs have entered the market place. It will explore barriers to access to essential and rational medicines including access to trials data; pricing and patents; health system barriers; and direct to consumer advertising. It will look at government controls over marketing and long term surveillance and pharmacovigilance and why fraudulent behaviour takes place.

Sorry, there are no lists here yet. You could try:

  • Clicking My Lists from the menu. Your course enrolled lists are stored here.
  • Searching for the list using the form below:

Lists linked to Medicines and Pharmaceuticals

There are currently no lists linked to this Module.